Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Sigma Healthcare Ltd ( (AU:SIG) ) has provided an announcement.
Sigma Healthcare Limited announced a trading update following its merger with Chemist Warehouse Group, revealing a 36% growth in Normalised EBIT for the nine months ending March 31, 2025, consistent with Chemist Warehouse’s performance for the first half of FY25. The merger is treated as a reverse acquisition for accounting purposes, with Chemist Warehouse as the accounting acquirer, and Sigma’s financial results for FY25 will include Chemist Warehouse’s financials from the merger date. The announcement highlights significant transaction costs and the impact of inter-company sales on earnings.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited operates in the healthcare industry, primarily focusing on pharmaceutical distribution and retail services. The company recently completed a merger with Chemist Warehouse Group, enhancing its market presence and operational capabilities.
YTD Price Performance: 8.99%
Average Trading Volume: 7,959
Technical Sentiment Signal: Sell
Current Market Cap: €20.31B
See more insights into SIG stock on TipRanks’ Stock Analysis page.